Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO
Hindustan Times

A candidate Ebola vaccine developed by Oxford University and the Serum Institute of India joined WHO clinical trials.
The candidate vaccine developed by the Oxford University and the Serum
Institute of India is among the two such vaccines added to the ongoing Ebola
clinical trials, according to a World Health Organisation (WHO) statement,
making it the first addition of candidate vaccines to the trials specifically
targeting the Bundibugyo virus that has caused the current Ebola outbreak in
the Democratic Republic of the Congo (DRC).




